Pulmatrix, Inc. (PULM)
$1.46-4.58%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $5M
- Beta
- 1.92
- P/E (TTM)
- -1.30
- Short % float
- 1.34%
- Days to cover
- 1.0
- SI change
- -11.5%
- 1W
- -7.01%
- 1M
- +0.00%
- vs SPY 1W
- -8.17%
- vs SPY 1M
- -2.99%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PULM?
- LOPJLB’s latest quantitative signal on Pulmatrix, Inc. (PULM) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PULM in?
- Pulmatrix, Inc. (PULM) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Pulmatrix, Inc. (PULM) do?
- Pulmatrix, Inc. (PULM) is a clinical-stage biotechnology firm focused on creating and advancing inhaled treatments. The company's primary goal is to address significant unmet medical needs in respiratory and other diseases within the United States. Central to their approach is the innovative iSPERSE (inhaled small particles easily respirable and emitted) technology. This proprietary platform al…